The Wilms' tumor usually presents with asymptomatic abdominal mass (
1). In children, any abdominal mass should be considered malignant unless otherwise specified by lab and imaging (
1,
3).
Wilms' tumor is the most common renal tumor in children and accounts for 6% of all pediatric malignancies. It mostly affects children less than 5 years old, with 90% of new cases diagnosed before age 3 years. The incidence rate is 8 patients per one million (
1). Wilms' tumor (WT) is mostly sporadic and about 2% have a positive family history (
1,
2).
The reported patient was a 2-year-old child presenting with an abdominal mass. This mass can enlarge since retroperitoneal masses can continue their development with no anatomic impediment and functional defects in the adjacent organs appear later (
1). In 4 to 10% of the patients, the thrombus induced by Wilms' tumor extends into the inferior vena cava and rarely into the right atrium (
1). Based on the tumor extension into the renal vein and inferior vena cava according to the classification proposed by Daum et al., tumor thrombus is classified into 4 stages (
2,
4). In stage I, the maximum length of the tumor thrombus is 5 cm, reaching the IVC and terminating at the lower hepatic edge. In stage II, the tumor reaches the junction of the hepatic vein. In stage III, tumor thrombus extends to the hepatic veins in 4 to 8% of the cases. In stage IV, tumor extends into the atrium and this stage has been observed in 1% of the cases.
The patients in stages II and IV occasionally present with IVC obstruction or congestive cardiac failure, in which case the outcome will be catastrophic (
5,
6) and when they present with heart failure, the outcome is often not good (
7). Wilms' tumor or intravenous thrombus is not clinically common in children (
8). In the reported patient, although tumor thrombus was in stage IV and had almost filled up the entire IVC, no IVC obstruction or heart failure symptoms had occurred. The basis of Wilms' tumor treatment in children is surgical excision of the tumor and tumor thrombus.
Chemotherapy is recommended to shrink the tumor and its fibrosis when the patient is in stage III or IV and has an atrial extension (
9,
10). When shrinkage does not occur in spite of pre-surgery chemotherapy and some progression is even observed, surgery must be carried out as soon as possible (
11,
12).
Since rupture of the tumor, extensive hemorrhage, and embolism are possible during surgery in cases with no prior chemotherapy, pre-operative chemotherapy is recommended, albeit for a few weeks, to reduce the tumor size and the likelihood of rupture during surgery and to prevent the spread of tumoral cells and their vascularization (
1,
2,
10,
13). Although mortality has been reported during chemotherapy as a result of complications such as hemorrhage and tumor (
14), chemotherapy can cause shrinkage of the tumor and sometimes IVC or reduce its extension into the right atrium (
2,
15).
In 30% of cases, even with preoperative chemotherapy, the persistent cavo-atrial tumor is still present or even spread (
9). In this situation, tumor resection with CPB is the best treatment option (
9).
In the presented patient, the size of the thrombus tumor did not change and the mass remained in the atrium despite 8 weeks of chemotherapy. In a study conducted by Xu et al. (2019), 42 cases of Wilms' tumor with tumor extended into the atrium, underwent cardiac surgery with CPB and cardiac arrest (
3). In that study, 10 out of 42 patients had intraventricular thrombosis (Daum stage IV) and completed a preoperative chemotherapy regimen. In 5 patients, tumor shrinkage happened and they did not require CPB during surgery. In 5 patients, eventually developed intraventricular thrombosis, CPB was performed by the cardiac surgeon. In all cases, the atrium was incised (
3). If CPB and cardiac arrest can be avoided, the side effects of CPB such as cytokines, interleukins, and other inflammatory mediators release may be preventable. It will also minimize the risk of bleeding, the need for blood transfusions, and the risk of heart function deficit.
Most patients in Daum stage IV will need CPB and cardiac arrest due to concerns about the possibility of adhesions, embolism, and rupture of the atrium walls. In our reported case, CPB and cardiac arrest were not performed, and no pulmonary embolism, tumor spread, or complications were observed.
Some Wilms tumors in stage III and IV are not sensitive to chemotherapy and in only 50% of cases, the tumor size may change. Even if the thrombus tumor responds to chemotherapy, the tumor needs to re-assess preoperatively, therefore, imaging studies will be needed (
3). In presented studies, no association between tumor thrombus and the pathological classification of WT was found.
The reported patient was followed up for 5 years (most recurrences occur within the first 2 years) and showed no evidence of embolism, metastasis, or tumor spread.
3.1. Conclusions
Wilms tumor treatment is a multidisciplinary approach. Cardiac surgeons' involvement is necessary if the patient is in stages III or IV. If the thrombotic tumor is observed in the right atrium, it may be removed without cardiac arrest. Decision will be made separately for each patient. If there is no adhesion to the atrial wall, surgery may be performed without CPB with precautions. In our reported case, cardiac surgery was performed without the use of CPB. Since surgeries are high-risk procedures, it was attempted to prevent further risk for the patient.